ArticleMaterials today. Bio2026

Conjugation strategy shapes antitumor efficacy and enables dose-sparing in non-antibody protein nanoconjugates.

Ariana Rueda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.